
Results
10
Companies which are more than 50% undervalued based on analyst price target.
10 companies
Prosus
Market Cap: €94.6b
Engages in the e-commerce and internet businesses in Asia, Europe, Latin America, North America, and internationally.
PRX
€39.61
7D
2.3%
1Y
-14.0%
CSG
Market Cap: €18.7b
Manufactures and sells defence products in the Czech Republic, Europe, the United States, and the Asia Pacific.
CSG
€19.31
7D
19.2%
1Y
n/a
Heineken Holding
Market Cap: €17.0b
Engages in brewing and selling beer and cider in the Netherlands, Europe, the Americas, Africa & Middle East, Asia Pacific and internationally.
HEIO
€63.25
7D
5.3%
1Y
-7.7%
Wolters Kluwer
Market Cap: €14.2b
Provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally.
WKL
€63.02
7D
8.0%
1Y
-60.6%
Exor
Market Cap: €13.4b
Engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally.
EXO
€66.90
7D
0.3%
1Y
-22.6%
Pharming Group
Market Cap: €783.9m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.12
7D
-0.7%
1Y
19.4%
Envipco Holding
Market Cap: €302.0m
Develops, manufactures, assembles, leases, sells, markets, and services a line of reverse vending machines (RVMs) in the Netherlands, the United States, North America, and Europe.
ENVI
€4.64
7D
-2.4%
1Y
-19.5%
Avantium
Market Cap: €210.0m
A chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands.
AVTX
€9.08
7D
12.9%
1Y
-32.9%
Cabka
Market Cap: €48.4m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
CABKA
€2.00
7D
-4.8%
1Y
4.2%
Vivoryon Therapeutics
Market Cap: €36.9m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.25
7D
-2.0%
1Y
-29.1%